A PYMNTS Company

US: Pharma transaction leads to takeover speculation

By  |  February 11, 2013

Pharmaceutical giant Regeneron Pharmaceuticals Inc has announced its drug-development ally Sanofi SA plans to increase its stock in the pharma company through a 5.3 percent purchase. In a statement, Sanofi said it is allowed to build its stock in Regeneron to up to 30 percent; Sanofi controls 16.7 percent currently, according to reports. Sanofi also denied speculation that the company is going after a controlling stake in the pharmaceutical company. The two have a longstanding partnership in drug development.

 

Full Content: Reuters

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.